Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Toxicol Appl Pharmacol. 2019 Oct 25;384:114783. doi: 10.1016/j.taap.2019.114783

Fig 3.

Fig 3.

Analysis of B cells and activated B cells by flow cytometry. Top panels are non-smokers and bottom panels are smokers. T (CD3+) and B (CD19+) cell populations were identified for non-smokers (A) and smokers (B), and the CD19+ cells were analyzed for activated B cells (CD19+ HLA-DR+) in two non-smokers (C) and two smokers (D).